Stamp out fake clinical data by working together.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Gene therapy for people with hepatocellular carcinoma.The Cochrane database of systematic reviews · 2024
   Pooled it
2. From the Catastrophic Objective Irreproducibility of Cancer Research and Unavoidable Failures of Molecular Targeted Therapies to the Sparkling Hope of Supramolecular Targeted Strategies.International journal of molecular sciences · 2023
   Review
3. The power of weak signals: how systematic reviews direct researchers away from potentially biased primary studies.The Cochrane database of systematic reviews · 2022
   Article
4. Automated detection of over- and under-dispersion in baseline tables in randomised controlled trials.F1000Research · 2022
   Article

Corrections and comments

• Comment on
  False individual patient data and zombie randomised controlled trials submitted to Anaesthesia.2021
• Comment on
  Ivermectin for preventing and treating COVID-19.2021

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as